Kezar Life Sciences's total assets for Q3 2024 were $164.09M, a decrease of -8.80% from the previous quarter. KZR total liabilities were $30.04M for the fiscal quarter, a 2.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.